FDA Approves Colcrys (colchicine) for Acute Gout, Mediterranean Fever
July 31, 2009
Agency also provides new information to physicians regarding safe use
of drug ROCKVILLE, Md., July 30, 2009--The U.S. Food and Drug
Administration has approved Colcrys to treat acute flairs in patients
with gout, a recurrent and painful form of arthritis, and patients
with familial Mediterranean fever (FMF), an inherited inflammatory
disorder. The medication's active ingredient is colchicine...
Agency also provides new information to physicians regarding safe use
of drug ROCKVILLE, Md., July 30, 2009--The U.S. Food and Drug
Administration has approved Colcrys to treat acute flairs in patients
with gout, a recurrent and painful form of arthritis, and patients
with familial Mediterranean fever (FMF), an inherited inflammatory
disorder. The medication's active ingredient is colchicine...
Comentarios
Publicar un comentario